Nuclear medicine techniques for detecting carcinoma in the dense

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

600429, 600431, 600436, A61K 5104, A61B 505

Patent

active

058956409

ABSTRACT:
A nuclear medicine technique for detecting and localizing carcinomas in the breasts of patients with dense breast. In the method, a patient with dense breast is administering a dose of Technetium-99m Sestamibi, or another nuclear medicine substance which selectively accumulates in breast carcinomas. The breast is then imaged with a nuclear medicine detector to image the carcinomas with the accumulated nuclear medicine agent and localize the carcinomas in real time and in three dimensions. The imaging can be done in a first plane with the detector perpendicular to a lateral side of the breast and also in a second plane parallel to the patient's chest wall.

REFERENCES:
patent: 4875478 (1989-10-01), Chen
patent: 5056523 (1991-10-01), Hotchkiss, Jr. et al.
patent: 5078142 (1992-01-01), Siczek et al.
patent: 5209232 (1993-05-01), Levene
patent: 5289520 (1994-02-01), Pellegrino et al.
patent: 5595177 (1997-01-01), Mena et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nuclear medicine techniques for detecting carcinoma in the dense does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nuclear medicine techniques for detecting carcinoma in the dense, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nuclear medicine techniques for detecting carcinoma in the dense will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2246356

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.